BRCA1 and BRCA2 in hereditary breast cancer

Biochimie

Volumn 84, Issue 1, 2002, Pages 95-102

  Scully, Ralph ^a   Puget, Nadine ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer; DNA repair; Homologous recombination; Tumor suppressor genes

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENE PRODUCT;

ALLELE; BIOLOGICAL MODEL; BREAST CANCER; CANCER SUSCEPTIBILITY; DNA REPAIR; FAMILIAL CANCER; GENE ACTIVITY; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN GENOME; NONHUMAN; OVARY CANCER; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0036247531     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01359-1     Document Type: Article

References (125)

1. Linkage of early-onset familial breast cancer to chromosome 17q21
2. Familial breast-ovarian cancer locus on chromosome 17q12-q23
3. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome
4. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds
5. High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families
6. Mutation and cancer: Statistical study of retinoblastoma
7. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
8. BRCA1 mutations in primary breast and ovarian carcinomas
9. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
10. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
11. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families
12. Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci
13. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
14. Identification of the breast cancer susceptibility gene BRCA2
15. BRCA2 mutations in primary breast and ovarian cancers
16. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer
17. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
18. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
19. The pathology of hereditary breast cancer
20. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
21. p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
22. BRCA mutations and survival in breast cancer
23. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations
24. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: Specific BRCA1 mutations and pathological characteristics
25. Gene-expression profiles in hereditary breast cancer
26. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
27. Methylation of the BRCA1 gene in sporadic breast cancer
28. Down-regulation of BRCA1 in human sporadic breast cancer; Analysis of DNA methylation patterns of the putative promoter region
29. Abberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells
30. Insights into the functions of BRCA1 and BRCA2
31. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
32. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
33. Cell cycle-dependent colocalization of BARD1 and BRCA1 protein in discrete nuclear domains
34. BRCA1 protein products functional motifs
35. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins
36. From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair
37. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue
38. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development
39. The BRC repeats are conserved in mammalian BRCA2 proteins
40. Association of BRCA1 with Rad51 in mitotic and meiotic cells
41. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
42. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
43. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
44. Analysis of murine brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals
45. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response
46. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
47. Redistribution of BRCA1 among four different protein complexes following replication blockage
48. Independence of R/M/N focus formation and the presence of intact BRCA1
49. DNA polymerase stalling, sister chromatid recombination and the BRCA genes
50. The breast cancer susceptibility gene, BRCA2: At the crossroads between DNA replication and recombination?
51. In search of the tumor suppressor functions of BRCA1 and BRCA2
52. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
53. Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
54. Brca2 is required for embryonic cellular proliferation in the mouse
55. Involvement of Brca2 in DNA repair
56. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability
57. Brca1 required for T cell lineage development but not TCR loci rearrangement
58. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation
59. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification
60. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
61. The human decatenation checkpoint
62. BRCA1 required for transcription-coupled repair of oxidative DNA damage
63. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2
64. Genetic analysis of BRCA1 function in a defined tumor cell line
65. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
66. Molecular mechanisms of DNA double strand break repair
67. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae
68. Initiation of genetic recombination and recombination-dependent replication
69. Replication fork arrest and DNA recombination
70. Coping with replication 'train wrecks' in escherichia coli using pol V, pol II and RecA proteins
71. Replication and recombination intersect
72. The importance of repairing stalled replication forks
73. Links between replication, recombination and genome instability in eukaryotes
74. Spontaneous and restriction enzyme-induced chromosomal recombination in mammalian cells
75. Genetic manipulation of genomes with rare-cutting endonucleases
76. Chromosomal double-strand breaks induce gene conversion at high frequency in mammalian cells
77. Brca1 controls homology-directed DNA repair
78. BRCA2 is required for homology-directed repair of chromosomal breaks
79. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation
80. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences
81. Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining
82. Transcriptional activation by BRCA1
83. Evidence for a transcriptional activation function of BRCA1 C-terminal region
84. Transcriptional activation functions in BRCA2
85. BRCA2 associates with acetyltransferase activity when bound to P/CAF
86. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer
87. BRCA1 interacts with components of the histone deacetylase complex
88. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression
89. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage
90. Sequence-specific transcriptional corepressor function for BRCA1 through a Novel Zinc Finger Protein, ZBRK1
91. The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins
92. BRCA1 at a branch point
93. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50
94. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression
95. BRCA1 is a component of the RNA polymerase II holoenzyme
96. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
97. Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
98. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
99. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
100. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex
101. BRCA1 RING domain cancer-predisposing mutations: Structural consequences and effects on protein-protein interactions
102. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function
103. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage
104. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks
105. Functional, interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
106. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
107. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site
108. Roles of BRCA1 and its interacting proteins
109. Direct DNA binding by Brca1
110. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2
111. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment
112. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition
113. The Bloom's syndrome gene product is homologous to RecQ helicases
114. Positional cloning of the Werner's syndrome gene
115. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response
116. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder
117. The DNA helicase activity of BLM is necessary for the correction of the genomic instability of bloom syndrome cells
118. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
119. Tumorigenesis in mice carrying a truncating Brca1 mutation
120. Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice
121. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
122. Constitutional genomic instability with inversions, duplications, and amplifications in 9p in BRCA2 mutation carriers
123. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells
124. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein